Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 6, 2022; 10(34): 12637-12647
Published online Dec 6, 2022. doi: 10.12998/wjcc.v10.i34.12637
Published online Dec 6, 2022. doi: 10.12998/wjcc.v10.i34.12637
Ref. | Age in yr/sex | Duration of symptom in mo | Main symptoms and signs | Location | Contrast enhancement | Tumor diameter in cm | ALK expression | Main treatment | Chemotherapy | Prognosis |
Present case | 67/F | 3 | Diplopia | Left middle cranial fossa | Intense | 2.4 | Negative | GTR | None | No recurrence |
Wang et al[5], 2019 | 21/F | 0.5 | Blurred vision | Right frontal lobe | Intense | 10.0 | Negative | GTR | None | No recurrence |
Wang et al[5], 2019 | 60/M | N/A | Gait disturbance | Cerebellar hemisphere | Intense | N/A | Negative | GTR | None | No recurrence |
Wang et al[5], 2019 | 48/F | Several | Paranoid | Right temporal lobe | Intense | 5.3 | Negative | GTR | None | No recurrence |
Wang et al[5], 2019 | 20/F | 0.75 | Headache | Right temporal lobe | Intense | 5.0 | Positive | GTR | None | 7 mo after 1st surgery |
Wang et al[5], 2019 | 82/F | 6 | Memory decrease | Right temporal lobe | Intense | N/A | N/A | GTR | None | No recurrence |
Wang et al[5], 2019 | 51/F | 1.5 | Headache | Cerebellar hemisphere | Intense | N/A | N/A | Biopsy | Steroid | N/A |
Kuang et al[5], 2016 | 53/M | 12 | Blurred vision | Pineal | Intense | N/A | N/A | GTR | None | No recurrence |
PascualGallego et al[7], 2013 | 47/F | N/A | Headache | Left temporooccipital lobe | Intense | N/A | Negative | GTR | None | 4 mo after 1st surgery |
Denis et al[19], 2013 | 26/M | 3 | Headache, blurred vision | Left frontal lobe | Intense | 2.0 | Positive | GTR | None | 2 mo after 1st surgery |
Denis et al[19], 2013 | 17/F | N/A | Seizures | Left frontal lobe | N/A | N/A | Positive | GTR | None | 2.5 yr after 1st surgery |
Denis et al[19], 2013 | 65/F | N/A | Blurred vision | Occipital lobe | Intense | 5.0 | Negative | STR | None | No recurrence |
Denis et al[19], 2013 | 43/M | 6 | Headache | Orbit | Intense | N/A | Negative | GTR | None | No recurrence |
Denis et al[19], 2013 | 7/M | N/A | N/A | Right temporal fossa | N/A | 2.0 | Positive | GTR | None | 1.5 yr after 1st surgery |
Denis et al[19], 2013 | 24/M | N/A | N/A | Left temporal lobe | N/A | N/A | Positive | GTR | None | 2 yr after 1st surgery |
Kolenc et al[18], 2013 | 77/F | N/A | Right partial motoric seizures | Left temporal lobe | Intense | N/A | Negative | Biopsy | Corticosteroids | No recurrence |
Moss et al[14], 2012 | 36/F | N/A | Diplopia | Left middle cranial fossa | Intense | N/A | Negative | STR | Corticosteroids | 24 mo after 1st surgery |
Moss et al[14], 2012 | 50/F | 5 | Headache | Cavernous sinus | Intense | N/A | Negative | Steroid | None | N/A |
Kato et al[28], 2011 | 60/M | N/A | Gait disturbance | Cerebellar | Intense | 1.8 | Negative | GTR | None | No recurrence |
de Oliveira et al[27], 2009 | 7/M | 3 | Headache | Right temporal fossa | Intense | 4.0 | Positive | GTR | None | 24 mo after 1st surgery |
Lui et al[2], 2009 | 60/F | N/A | Blurred vision | Cerebral falx | Intense | N/A | Negative | GTR | Radiation therapy | No recurrence |
Lui et al[2], 2009 | 52/F | N/A | N/A | Right ventricle | Intense | N/A | Negative | GTR | None | No recurrence |
Lui et al[2], 2009 | 45/M | N/A | Left-sided weakness | Right frontal lobe | N/A | N/A | Negative | GTR | None | No recurrence |
Lui et al[2], 2009 | 26/F | 6 | Blurred vision | Left occipital lobe | Intense | N/A | Negative | Biopsy | Corticosteroids, thalidomide | No recurrence |
Swain et al[6], 2008 | 8/M | N/A | Attention deficiency | Left temporal lobe | Intense | N/A | Negative | STR | None | No recurrence |
Swain et al[6], 2008 | 28/F | N/A | Seizure | Left occipital lobe | Intense | 0.8 | Positive | GTR | None | No recurrence |
Swain et al[6], 2008 | 30/M | N/A | Headache | Posterior fossa | N/A | N/A | Negative | GTR | Radiation therapy | No recurrence |
Swain et al[6], 2008 | 31/F | 1 | Headache | Right frontal lobe | N/A | N/A | N/A | GTR | None | No recurrence |
Swain et al[6], 2008 | 74/F | N/A | Headache, seizures | Right parietal lobe | N/A | 3.8 | GTR | None | No recurrence | |
Swain et al[6], 2008 | 0.8/F | N/A | Seizures | Right temporal lobe | N/A | 8.4 | GTR | None | No recurrence | |
Miyahara et al[20], 2008 | 73/M | 1 | Gait disturbance | Paracele | N/A | N/A | N/A | GTR | Steroid | Died of complications |
Miyahara et al[20], 2008 | 48/M | N/A | Memory decrease | Paracele | N/A | N/A | N/A | GTR | Steroid | No recurrence |
Miyahara et al[20], 2008 | 18/M | N/A | N/A | Paracele | N/A | N/A | N/A | GTR | Steroid | No recurrence |
Miyahara et al[20], 2008 | 63/F | N/A | Headache | Paracele | N/A | N/A | N/A | GTR | Steroid | No recurrence |
Miyahara et al[20], 2008 | 50/M | 0.3 | Blepharoptosis | Left orbit, cavernous sinus | Intense | 1.5 | Negative | Biopsy | Corticosteroids | Progressive reduction |
Jeon et al[1], 2005 | 43/M | N/A | Dizziness | Orbit, falx, sup. sagittal sinus, tentorium | N/A | N/A | Negative | STR | Corticosteroids | 12 yr after 1st surgery |
Jeon et al[1], 2005 | 31/M | N/A | Headache, ptosis | Cavernous sinus | Intense | 1.5 | Negative | GTR | None | No recurrence |
Jeon et al[1], 2005 | 41/M | N/A | N/A | Temporal lobe | Intense | N/A | Negative | STR | None | No recurrence |
Jeon et al[1], 2005 | 29/M | N/A | Aphasia | Temporal and frontal lobes | Intense | N/A | Negative | Steroid | None | No recurrence |
Jeon et al[1], 2005 | 42/M | N/A | N/A | Subdura | Intense | N/A | Negative | GTR | None | No recurrence |
Jeon et al[1], 2005 | 50/M | N/A | Seizures | Frontal lobe | Intense | 5.0 | Negative | STR | None | No recurrence |
Jeon et al[1], 2005 | 52/F | N/A | Seizures | Occipital lobe | Intense | N/A | Negative | GTR | None | No recurrence |
Jeon et al[1], 2005 | 24/F | N/A | Diplopia | Orbit | Intense | N/A | Negative | GTR | None | No recurrence |
Jeon et al[1], 2005 | 65/F | N/A | N/A | Occipital lobe | Intense | 4.0 | Negative | GTR | None | 7 yr after 1st surgery |
Roche et al[10], 2004 | 20/F | 0.3 | Headache | Left temporal lobe | Intense | N/A | N/A | STR | Corticosteroids | Dramatic decrease in the mass size |
Hausler et al[11], 2003 | N/A/M | N/A | Seizures | Left temporal lobe | N/A | N/A | Negative | STR | None | No recurrence |
Hausler et al[11], 2003 | 15/M | N/A | Seizures | Occipital lobe | Intense | N/A | N/A | STR | Radiation therapy | No recurrence |
Hausler et al[11], 2003 | 17/F | N/A | Headache | Left frontal lobe | Intense | 6.0 | Positive | GTR | None | 20 mo after 1st surgery |
Buccoliero et al[9], 2003 | 70/M | 6 | Partial loss of vision | The bottom of the frontal lobes | Intense | 2.0 | Negative | Biopsy | Corticosteroids, radiation therapy | No remission |
- Citation: Su ZJ, Guo ZS, Wan HT, Hong XY. Inflammatory myofibroblastic tumor of the central nervous system: A case report. World J Clin Cases 2022; 10(34): 12637-12647
- URL: https://www.wjgnet.com/2307-8960/full/v10/i34/12637.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i34.12637